J. Proctor

发表

Three dimensional reconstruction of disseminated cancer modules.

S D Chawla, J W Proctor, S. Chawla, 1981, Cancer biochemistry biophysics.

Assessment of "best practice" treatment patterns for a "radiation oncology community outreach group" engaged in cancer disparities outcomes.

C. Saw, M. Dougherty, S. Rakfal, 2008, Journal of the American College of Radiology : JACR.

A screening tool to enhance clinical trial participation at a community center involved in a radiation oncology disparities program.

J. Proctor, L. L. Schenken, Elaine F Martz, 2011, Journal of oncology practice.

RECOGNITION FACTORS AND NONSPECIFIC MACROPHAGE ACTIVATION IN THE TREATMENT OF NEOPLASTIC DISEASE *

J. Proctor, P. Mansell, G. Rowden, 1976, Annals of the New York Academy of Sciences.

A simple and effective daily pain management method for patients receiving radiation therapy for painful bone metastases.

J. Proctor, R. Slack, R. Andrade, 2010, International journal of radiation oncology, biology, physics.

Inexpensive solutions to enhance remote cancer care in community hospitals

D. Heron, E. Ricci, S. Rakfal, 2013 .

Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system.

C. Rudenstam, J. Proctor, P. Alexander, 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

2555 : The Utility of TELESYNERGY® Videoconferencing Systems for Support of QA/CQI and Professional Communication in Radiation Oncology Facilities

S. Rakfal, J. Proctor, L. L. Schenken, 2006 .

Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas.

J. Haskill, J. Proctor, Y. Yamamura, 1975, Journal of the National Cancer Institute.

Autoimmunization with Irradiated Tumour Cells in Human Malignant Melanoma

T. Phillips, J. Proctor, G. Fairley, 1970, British medical journal.

Endocrine Factors and the Growth and Spread of 816 Melanoma

J. Proctor, L. Stokowski, B. Auclair, 1976 .

Further studies on endocrine factors and the growth and spread of B16 melanoma.

J. Proctor, Y. Yamamura, D. Gaydos, 1981, Oncology.

Cellular localization of immunoglobulin within human maglignant melanomata.

T. Phillips, J. Proctor, G. Rowden, 1976, British Journal of Cancer.

In-vitro interactions between antitumour antibodies and anti-antibodies in malignancy.

J. Proctor, D. Hartmann, M. Lewis, 1974, Lancet.

A Factor Preventing the Development of Lung Metastases in Rats with Sarcomas

C. Rudenstam, J. Proctor, P. Alexander, 1973, Nature.

Comparison of effect of BCG, glucan and levamisole on B16 melanoma metastases.

H. Shibata, J. Proctor, L. Stokowski, 1977, European journal of cancer.

Rat sarcoma model supports both "soil seed" and "mechanical" theories of metastatic spread.

J. Proctor, 1976, British Journal of Cancer.

Impairment of systemic concomitant antitumor immunity by excess soluble tumor antigen

J. Proctor, D. Thomson, M. Sutherland, 1980, Cancer Immunology, Immunotherapy.

The distribution and fate of blood‐borne 125 iudr‐labelled tumour cells in immune syngeneic rats

J. Proctor, B. G. Auclair, C. M. Rudenstam, 1976, International journal of cancer.

Tube leukocyte adherence inhibition assay for the detection of anti‐tumour immunity. I. Monocyte is the reactive cell

J. Proctor, D. Thomson, N. Grosser, 1976, International journal of cancer.

Differences in mitogenic responses of murine T cells to two distinct phytohemagglutinin (PHA) subcomponents.

K. Madyastha, J. Proctor, H. Fudenberg, 1981, Immunological communications.

Endrocrine factors and the growth and spread of B16 melanoma.

J. Proctor, L. Stokowski, B. Auclair, 1976, Journal of the National Cancer Institute.

The effect of BCG on B16 mouse melanoma: a comparison of routes of administration on tumour growth at different anatomical sites.

J. Proctor, M. Lewis, B. Auclair, 1976, European journal of cancer.

Collaboration between specific anti‐tumor immunity and chemotherapeutic agents

B. Fischer, J. Proctor, J. Harnaha, 1980, International journal of cancer.

Development of a bioassay for the antitumor activity of biological response modifiers of the reticuloendothelial stimulant class

J. Proctor, J. Harnaha, Y. Yamamura, 1981, Cancer Immunology, Immunotherapy.

Development of a bioassay for anti tumor activity of biological response modifiers of the reticuloendothelial stimulant class: reproducibility of the bioassay.

J. Proctor, Y. Yamamura, P. Mansell, 1981, Journal of immunopharmacology.

Immunological responses to a murine mammary adenocarcinoma. outgrowth of pulmonary occult metastases induced by immunosuppressive perturbations

J. Proctor, Y. Yamamura, P. Braunschweiger, 1984, International journal of cancer.

Heterogeneity of murine mammary adenocarcinoma cell subpopulations. in vitro and in vivo resistance to macrophage cytotoxicity and its association with metastatic capacity

B. Fischer, J. Proctor, J. Harnaha, 1984, International journal of cancer.

A simple procedure for removal of intra- and extra-tumoral macrophages from primary tumor cultures

K. Madyastha, J. Proctor, Y. Yamamura, 1981, Experientia.

TUBE LEUKOCYTE ADHERENCE INHIBITION ASSAY FOR THE THE REACTIVE CELL DETECTION OF ANTI-TUMOUR TMMUNITY. I. MONOCYTE IS

J. Proctor, D. Thomson, N. Grosser, 2006 .

Evaluation of Patient Navigation in a Community Radiation Oncology Center Involved in Disparities Studies: A Time-to-Completion-of-Treatment Study.

E. Ricci, J. Proctor, R. Slack, 2008, Journal of oncology practice.